Previous 10 | Next 10 |
2023-12-12 12:16:51 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Petros Pha...
2023-12-12 10:50:59 ET The Aditxt (NASDAQ: ADTX) stock price jumped by more than 83% on Tuesday, making it one of the best performers in Wall Street. The shares surged to a high of $9.47, its highest point since October 19th. At its peak, the stock was up by more than 195% from its lowe...
2023-12-12 09:59:18 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Candel Therapeuti...
2023-12-12 09:06:38 ET DENVER, Colo., Dec. 12, 2023 ( www.247marketnews.com )- The following companies are our five favorite trades of the day; Siyata Mobile Inc. (NASDAQ: SYTA), Aditxt Inc (NASDAQ: ADTX), C4 Therapeutics Inc. (NASDAQ: CCCC), IN8bio Inc. (NASDAQ: INAB), Alphabet Inc (NA...
2023-12-12 08:59:04 ET More on Evofem Biosciences Evofem Biosciences expects to see third consecutive quarter of growth Evofem says no Phexxi generic until 2033 after company amends ANDA Financial information for Evofem Biosciences For further details see: ...
Evofem posted $13.4 million in net sales of Phexxi for the first nine months of 2023; Aditxt looks to accelerate Evofem into the global non-hormonal birth control market valued at $27.7 billion in 2022 and is projected to grow to $52.2 billion by 2031 Aditxt, Inc. ( ...
2023-12-08 08:27:04 ET More on pr-market losers $ stocks. Aditxt appoints Ernie Lee as CEO of its wholly-owned subsidiary, Pearsanta IPO Roundup: WeBuy Global, Maison Solutions and more Seeking Alpha’s Quant Rating on Aditx Therapeutics Historical earn...
2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...
2023-11-30 10:00:02 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Redhill Biopharma, Ampio Pharmaceuticals among healthcare movers
2023-11-30 08:06:09 ET Aditxt ( ADTX ) +66% . Clearmind Medicine ( CMND ) +63% . Ampio Pharmaceuticals ( AMPE ) +63% . Smart for Life ( SMFL ) +29% . China SXT Pharmaceuticals ( SXTC ) +28% . VinFast Auto ( VFS ) ...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...